摘要
目的 探讨围手术期输血对膀胱癌根治术患者预后的影响。方法 回顾性分析接受膀胱癌根治术的患者41例,其中围手术期输血组27例和未输血组14例,比较两组患者的总生存期、术后肿瘤复发率,术区淋巴结有无肿大转移和有无其他脏器转移并进行预后危险因素分析。结果 输血组和未输血组之间生存分析比较,输血组较未输血组可延长膀胱癌根治术患者的生存期(χ2=7.564,P<0.01)。不同输血量之间预后存在差异性(F=4.497,P<0.01),输血量越大,预后越差。结论 围手术期输血是影响膀胱癌患者预后的独立危险因素;输血量越大,患者的总生存期越短;其影响力度不受其他因素的影响,这为临床上合理输血及适度治疗提供了参考价值。
关键词: 围手术期输血;膀胱癌;生存分析;根治性切除术后
Abstract
Objective: To investigate the effect of perioperative blood transfusion on the prognosis of patients undergoing radical surgery for bladder cancer. Methods A retrospective analysis was made of 41 patients who underwent radical resection of bladder cancer, including 27 patients in the perioperative blood transfusion group and 14 patients in the non blood transfusion group. The total survival period, tumor recurrence rate after surgery, lymph node enlargement and metastasis in the operation area and other organ metastasis were compared between the two groups, and prognostic risk factors were analyzed. Results The survival analysis and comparison between the blood transfusion group and the non blood transfusion group showed that the survival period of the patients with bladder cancer undergoing radical surgery in the blood transfusion group was longer than that in the non blood transfusion group(χ2=7.564,P<0.01). There were differences in prognosis among different blood transfusion volumes (F=4.497, P<0.01). The larger the blood transfusion volume, the worse the prognosis. Conclusion Perioperative blood transfusion is an independent risk factor for the prognosis of bladder cancer patients; The larger the blood transfusion volume, the shorter the total survival time of patients; Its influence is not affected by other factors, which provides reference value for rational blood transfusion and appropriate treatment in clinical practice.
Key words: Perioperative blood transfusion; Bladder cancer; Survival analysis; After radical resection
参考文献 References
[1] 黄燊香,刘秋梅,林银霞,莫小婷,韦燕飞,徐敏,刘淑珍,张君玲,韦春梅,覃健,陆浩源.膀胱癌患者术后复发相关影响因素分析[J].广西医科大学学报,2022,39(06):918-922.
[2] 王亮,张建超,李翠萍. 围手术期异体输血对原发性膀胱癌根治术患者外周血PD-1/PD-L1表达及术后生存的影响[J]. 国际泌尿系统杂志,2020,40(6):983-987.
[3] 马金鹏,何康,邓姣,等. 围手术期输血对肾癌术后患者预后影响的Meta分析[J]. 现代肿瘤医学,2022,30(7): 1244-1248.
[4] 刘雅珺. 围手术期输血与恶性肿瘤患者的免疫抑制[J]. 世界最新医学信息文摘(连续型电子期刊),2020, 20(26): 289.
[5] 张帆,朱昭琼,刘德行,等. 不同围术期输血策略对恶性肿瘤患者预后的影响[J]. 临床麻醉学杂志,2021, 37(8): 865-867.
[6] 赵永录,张兴盛,宋广智,等. 经尿道二次电切在pT1期非肌层浸润性膀胱癌的预后价值研究[J]. 中华腔镜泌尿外科杂志(电子版),2022,16(4):316-319.
[7] 刘丽萍,胡燕,何霞,等. 红细胞输血在晚期肿瘤中的影响及预后价值[J]. 临床血液学杂志,2022,35(4): 252-255, 259.
[8] 屈常伟,骆喜宝,刘志贵等.预存式自体输血对结直肠癌患者围术期细胞免疫功能的影响[J].实用医学杂志,2013,29(18):2986-2988.DOI:10.3969.
[9] 朱理辉,霍继荣,张琍等.DC-CIK联合TACE治疗原发性肝癌的疗效分析[J].实用肿瘤杂志,2016,31(2):174-179.